LY2228820 dimesylate
LY2228820 dimesylate (Ralimetinib) is a potent, selective, orally available inhibitor p38 MAPK with IC50 of 5.3 and 3.2 nM for p38α and p38β, respectively.
Product Specifications
CAS Number
862507-23-1
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
612.737
Molecular Formula
C26H37FN6O6S2
Notes
Research use only, not for human use.
Receptor
P38α
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6198655-01 0.1 mL
YY1 (YY1 Transcription Factor, DELTA, INO80S, NF-E1, UCRBP, YIN-YANG-1) (MaxLight 405)
Ask
View Details MBS6198655-02 5x 0.1 mL
YY1 (YY1 Transcription Factor, DELTA, INO80S, NF-E1, UCRBP, YIN-YANG-1) (MaxLight 405)
Ask
View Details L2020-73N-Biotin 200 µL
Leucine Rich Repeat and Ig Domain Containing 1, NT (Leucine-rich Repeat and Immunoglobulin-like Domain-containing Nogo Receptor-interacting Protein 1, Lingo 1, LINGO1, Lingo-1, FLJ14594, Leucine-rich Repeat and Immunoglobilin Domain-containing Protein 1, Leucine-rich Repeat Neuronal Protein 1, LERN1, Leucine-rich Repeat Neuronal Protein 6A, LRRN6A, MGC17422, UNQ201/PRO227) (Biotin) discontinued
Ask
View Details